C12N 2710/14061
Methods of inactivation or attenuation
C12N2710/14061 (Methods of inactivation or attenuation) appears on 3 US grants and 3 published applications in this corpus.
Search patents in C12N- Granted patents
- 3
- Published applications
- 3
- Assignees
- 2
- Inventors
- 9
- Latest grant
- 7 Jul 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2000 | 1 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 0 |
| 2016 | 0 | 0 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 0 |
| 2020 | 0 | 0 |
| 2021 | 0 | 0 |
| 2022 | 0 | 1 |
| 2023 | 0 | 0 |
| 2024 | 1 | 1 |
| 2025 | 0 | 0 |
| 2026 | 1 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Method of producing an immunogenic composition7 Jul 2026US 12,673,094 B2Boehringer Ingelheim Animal Health USA Inc.
- Method of producing an immunogenic composition16 Apr 2024US 11,957,746 B2
- Recombinant insect virus with reduced capacity for host-to-host transmission in the environment and methods to produce said virus10 Oct 2000US 6,130,074 AAmerican Cyanamid Company Five Giralda Farms
- Method of producing an immunogenic composition30 Jul 2026US 2026/0216312 A1Boehringer Ingelheim Animal Health USA Inc.
- Method of producing an immunogenic composition24 Oct 2024US 2024/0350612 A1Boehringer Ingelheim Animal Health USA Inc.
- Method of producing an immunogenic composition29 Dec 2022US 2022/0409715 A1Boehringer Ingelheim Animal Health USA Inc.
Most cited
By later US patents